MOLECULAR CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2019-07-12 178Nht12508(PJ LOVE TYQ)

审稿速度:1.0 | 投稿命中率:50.0
经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst

130 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2019-07-03 洋娃娃

审稿速度:1.0
经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会

121 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2019-06-18 145b138dm45暂无昵称

请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表:
刚投了，没需要

156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要

90 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2019-06-18 145b138dm45暂无昵称

请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表:
投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼

156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼

109 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2019-05-23 120cc505m10(暂无昵称)

需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表::
请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表:
请问是否需要提供细胞证明和所有原始数据？

119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？

102 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2019-04-29 fw独家记忆

这杂志都没什么人投吗

103 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2019-03-02 sunliang

AACR旗下杂志还不错，但这个有点力不从心

104 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2018-12-10 119254319

现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表::
QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表:
QC一周了！怎么办？

135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？

136 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2018-11-28 1230796am72(暂无昵称)

QC一周了！怎么办？

173 0

[GetPortalCommentsPageByObjectIdResponse(id=573607, encodeId=6e8b5e360746, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：4月10号投5月小修，6月份给接收决定，7月份Onlinefirst, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/702e592d3f763e5f34c3d2da13c14dfd/9a392199ec6172ed10798ba478722144.jpg, createdBy=ae322459532, createdName=178Nht12508(PJ LOVE TYQ), createdTime=Fri Jul 12 00:00:00 CST 2019, time=2019-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573253, encodeId=b85b5e32538b, content=审稿速度:1.0 经验分享：五月底投的，很快就送审了，一审一个月，三个审稿人，给了很多意见，第一个第二个审稿人评价偏正面，第三个审稿人说我创新不足，没有提供细胞系证明等，编辑把我拒了，没给修回机会, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLrGXb8M9OEpHTCgfdI5vnXyibqUgs6tER97ib90YlyvUuAibXuDj63JmGmBwxfb17rCgYhacFYxtJeA/132, createdBy=0f492502991, createdName=洋娃娃, createdTime=Wed Jul 03 00:00:00 CST 2019, time=2019-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572391, encodeId=f9225e239194, content=请问一下endnote参考文献合适文件在哪可以找到？156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, beContent=156****2454(暂无匿称) 2018-09-18 00:00:00 发表: 刚投了，没需要, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572390, encodeId=e0905e239086, content=请问一下参考文献合适在哪有endnote文件？156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f5575080670, createdName=145b138dm45暂无昵称, createdTime=Tue Jun 18 00:00:00 CST 2019, time=2019-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571385, encodeId=8f305e138517, content=需要啊！投稿须知上写的很清楚119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？119254319 2018-11-05 23:21:00 发表: 请问是否需要提供细胞证明和所有原始数据？, beContent=119254319 2018-11-05 发表:: 请问是否需要提供细胞证明和所有原始数据？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 23 00:00:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570208, encodeId=e03e5e02084b, content=这杂志都没什么人投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83ep8bWkhQUsZRaEWSVzZypqhCA6SsKStNQJ65SIwWKEFXGJRu0CoDB0GX3IjDXYOGeia1iaZL7W9L6sw/132, createdBy=f6902080981, createdName=fw独家记忆, createdTime=Mon Apr 29 00:00:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567511, encodeId=e7d056e5117c, content=AACR旗下杂志还不错，但这个有点力不从心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Mar 02 00:00:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564270, encodeId=18b65642e0d8, content=现在怎么样了，外审了吗？135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？135RLNC9472(暂无昵称) 2018-11-28 00:00:00 发表: QC一周了！怎么办？, beContent=135RLNC9472(暂无昵称) 2018-11-28 发表:: QC一周了！怎么办？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a22794, createdName=119254319, createdTime=Mon Dec 10 00:00:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563725, encodeId=4efc563e2547, content=QC一周了！怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563679, encodeId=f9605636e9d5, content=一审多久？156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, beContent=156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼, objectType=tool_impact_factor, channel=null, level=null, likeNumber=185, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epldREB36QG335PCq3OUuKCtpY39oCg1HNGlrpvUZNzzNRLGe67NvAiamEGgYSOzt7q47fyB6J9N5g/132, createdBy=0cac2377575, createdName=1230796am72(暂无昵称), createdTime=Tue Nov 27 00:00:00 CST 2018, time=2018-11-27, status=1, ipAttribution=)]

2018-11-27 1230796am72(暂无昵称)

一审多久？156****2454(暂无匿称) 2018-10-09 发表::
投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼156****2454(暂无匿称) 2018-10-09 00:00:00 发表:
投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼

156****2454(暂无匿称) 2018-10-09 发表:: 投稿32天，还在under review...有点方，重点是目前一个审稿人意见都没回，不知道什么鬼

185 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务